These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 35985997)
1. METTL3 promotes prostatic hyperplasia by regulating PTEN expression in an m Li J; Yao H; Huang J; Li C; Zhang Y; Xu R; Wang Z; Long Z; Tang J; Wang L Cell Death Dis; 2022 Aug; 13(8):723. PubMed ID: 35985997 [TBL] [Abstract][Full Text] [Related]
2. MIR663AHG as a competitive endogenous RNA regulating TGF-β-induced epithelial proliferation and epithelial-mesenchymal transition in benign prostate hyperplasia. Tong S; Mo M; Hu X; Wu L; Chen M; Zhao C J Biochem Mol Toxicol; 2023 Sep; 37(9):e23391. PubMed ID: 37518988 [TBL] [Abstract][Full Text] [Related]
3. miR-1202 regulates BPH-1 cell proliferation, apoptosis, and epithelial-to-mesenchymal transition through targeting HMGCL. Wang Z; Yin X; Yang P; Gong B; Liu H Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(5):675-687. PubMed ID: 38551020 [TBL] [Abstract][Full Text] [Related]
4. The m Qin Y; Qiao Y; Li L; Luo E; Wang D; Yao Y; Tang C; Yan G Life Sci; 2021 Jun; 274():119366. PubMed ID: 33741419 [TBL] [Abstract][Full Text] [Related]
5. The m6A methyltransferase METTL3 contributes to Transforming Growth Factor-beta-induced epithelial-mesenchymal transition of lung cancer cells through the regulation of JUNB. Wanna-Udom S; Terashima M; Lyu H; Ishimura A; Takino T; Sakari M; Tsukahara T; Suzuki T Biochem Biophys Res Commun; 2020 Mar; 524(1):150-155. PubMed ID: 31982139 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-β-catenin signaling axis and static & dynamic dual roles. Shan S; Su M; Li Y; Wang Z; Liu D; Zhou Y; Fu X; Yang S; Zhang J; Qiu J; Liu H; Zeng G; Chen P; Wang X; DiSanto ME; Guo Y; Zhang X Mol Med; 2023 Oct; 29(1):139. PubMed ID: 37864185 [TBL] [Abstract][Full Text] [Related]
7. METTL3 Mediates Epithelial-Mesenchymal Transition by Modulating FOXO1 mRNA N Feng Y; Yuan P; Guo H; Gu L; Yang Z; Wang J; Zhu W; Zhang Q; Cao J; Wang L; Jiao Y Adv Sci (Weinh); 2023 Jun; 10(17):e2204784. PubMed ID: 37072646 [TBL] [Abstract][Full Text] [Related]
8. Hesperidin ameliorates benign prostatic hyperplasia by attenuating cell proliferation, inflammatory response, and epithelial-mesenchymal transition via the TGF-β1/Smad signaling pathway. Kim HJ; Jin BR; An HJ Biomed Pharmacother; 2023 Apr; 160():114389. PubMed ID: 36791565 [TBL] [Abstract][Full Text] [Related]
9. Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial-mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway. Liu D; Liu J; Li Y; Liu H; Hassan HM; He W; Li M; Zhou Y; Fu X; Zhan J; Wang Z; Yang S; Chen P; Xu D; Wang X; DiSanto ME; Zeng G; Zhang X Prostate; 2021 Dec; 81(16):1435-1449. PubMed ID: 34553788 [TBL] [Abstract][Full Text] [Related]
10. M2a macrophage can rescue proliferation and gene expression of benign prostate hyperplasia epithelial and stroma cells from insulin-like growth factor 1 knockdown. Qian Q; He W; Liu D; Yin J; Ye L; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X Prostate; 2021 Jun; 81(9):530-542. PubMed ID: 33861464 [TBL] [Abstract][Full Text] [Related]
11. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer. Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495 [TBL] [Abstract][Full Text] [Related]
12. LPS/TLR4 Signaling Enhances TGF-β Response Through Downregulating BAMBI During Prostatic Hyperplasia. He Y; Ou Z; Chen X; Zu X; Liu L; Li Y; Cao Z; Chen M; Chen Z; Chen H; Qi L; Wang L Sci Rep; 2016 May; 6():27051. PubMed ID: 27243216 [TBL] [Abstract][Full Text] [Related]
13. Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development. Lu T; Lin WJ; Izumi K; Wang X; Xu D; Fang LY; Li L; Jiang Q; Jin J; Chang C Mol Endocrinol; 2012 Oct; 26(10):1707-15. PubMed ID: 22915828 [TBL] [Abstract][Full Text] [Related]
14. Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia. Shao R; Shi J; Liu H; Shi X; Du X; Klocker H; Lee C; Zhu Y; Zhang J Prostate; 2014 Jun; 74(9):970-82. PubMed ID: 24752964 [TBL] [Abstract][Full Text] [Related]
15. Aberrant Transforming Growth Factor-β Activation Recruits Mesenchymal Stem Cells During Prostatic Hyperplasia. Wang L; Xie L; Tintani F; Xie H; Li C; Cui Z; Wan M; Zu X; Qi L; Cao X Stem Cells Transl Med; 2017 Feb; 6(2):394-404. PubMed ID: 28191756 [TBL] [Abstract][Full Text] [Related]
16. Integrating spatial transcriptomics and single-cell RNA-sequencing reveals the alterations in epithelial cells during nodular formation in benign prostatic hyperplasia. Fei X; Liu J; Xu J; Jing H; Cai Z; Yan J; Wu Z; Li H; Wang Z; Shen Y J Transl Med; 2024 Apr; 22(1):380. PubMed ID: 38654277 [TBL] [Abstract][Full Text] [Related]
17. The miR-223-3p/MAP1B axis aggravates TGF-β-induced proliferation and migration of BPH-1 cells. Wang Z; Zhang Y; Zhao C; Li Y; Hu X; Wu L; Chen M; Tong S Cell Signal; 2021 Aug; 84():110004. PubMed ID: 33839256 [TBL] [Abstract][Full Text] [Related]
18. Methyltransferase-like 3 aggravates endoplasmic reticulum stress in preeclampsia by targeting TMBIM6 in YTHDF2-dependent manner. Chen Y; Liu X; Li L; He X; Zheng F; Zhang Y; Gao H; Jin Z; Wu D; Wang Q; Tao H; Zhao Y; Liu W; Zou L Mol Med; 2023 Feb; 29(1):19. PubMed ID: 36747144 [TBL] [Abstract][Full Text] [Related]
19. Curcumin attenuates prostatic hyperplasia caused by inflammation Liu Y; Wang Z; Gan Y; Chen X; Zhang B; Chen Z; Liu P; Li B; Ru F; He Y Pharm Biol; 2021 Dec; 59(1):1026-1035. PubMed ID: 34357837 [TBL] [Abstract][Full Text] [Related]
20. METTL3 attenuates proliferative vitreoretinopathy and epithelial-mesenchymal transition of retinal pigment epithelial cells via wnt/β-catenin pathway. Ma X; Long C; Wang F; Lou B; Yuan M; Duan F; Yang Y; Li J; Qian X; Zeng J; Lin S; Shen H; Lin X J Cell Mol Med; 2021 May; 25(9):4220-4234. PubMed ID: 33759344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]